Cargando…
Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
Obesity and metabolic syndrome are growing epidemics worldwide and greatly responsible for many liver diseases, including nonalcoholic fatty liver disease (NAFLD). NAFLD often progresses to cirrhosis, end-stage liver failure and hepatocellular carcinoma (HCC), the most common primary liver cancer an...
Autores principales: | Afonso, Marta B., Rodrigues, Pedro M., Simão, André L., Castro, Rui E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810101/ https://www.ncbi.nlm.nih.gov/pubmed/26950158 http://dx.doi.org/10.3390/jcm5030030 |
Ejemplares similares
-
Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jin, Yu, et al.
Publicado: (2019) -
Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
por: Cermelli, Silvia, et al.
Publicado: (2011) -
Circulating MicroRNAs as Biomarkers for Sepsis
por: Benz, Fabian, et al.
Publicado: (2016) -
Circulating microRNAs as Promising Biomarkers in Colorectal Cancer
por: Rapado-González, Óscar, et al.
Publicado: (2019) -
Infant circulating MicroRNAs as biomarkers of effect in fetal alcohol spectrum disorders
por: Mahnke, Amanda H., et al.
Publicado: (2021)